Meds A-Z
Cefovecin
Detailed information about Cefovecin
Pet Owner Quick Guide
Start here: what this medicine is for, what it does, and when it's usually needed.
Usually used for:
For the treatment of skin infections (secondary superficial pyoderma, abscesses, and wounds) in dogs caused by susceptible strains of Staphylococcus intermedius and Streptococcus canis (Group G).
What it does:
For the treatment of skin infections (wounds and abscesses) in cats caused by susceptible strains of Pasteurella multocida . For the treatment of skin infections (secondary superficial pyoderma, abscesses, and wounds) in...
When it's needed:
Federal law restricts this drug to use by or on the order of a licensed veterinarian. For subcutaneous use in dogs and cats only. Federal law restricts this drug to use by or on the order of a licensed veterinarian. Maxi...
Call your vet sooner if you notice:
- Federal law restricts this drug to use by or on the order of a licensed veterinarian. For subcutaneous use in dogs and cats only. Federal law restricts this drug to use by or on the order of a licensed veterinarian. Maximum treatment should not exceed 2 injections. For subcutaneous use in dogs and cats only.
Commonly reported reactions:
- (2 reports)
- (2 reports)
- (1 reports)
What to ask your vet today:
- Is this medicine the right fit for my pet’s current symptoms?
- Which warning signs mean I should call back right away?
- How should I handle missed doses or refusal to take the medicine?
Cefovecin
Drug type: Generic ingredient • Branded profile • FDA branded products available
Species: Both
Manufacturer: MSK
Quick Facts
Official label facts first, then secondary summaries. Marketing content is separated below.
- https://animaldrugsatfda.fda.gov/adafda/views/#/home/previewsearch/200812 · official_label · FDA application profile
- https://animaldrugsatfda.fda.gov/adafda/views/#/home/previewsearch/141285 · official_label · FDA application profile
- https://animaldrugsatfda.fda.gov · fda_animal_drugs · Medication usage source
Warnings / Contraindications
Federal law restricts this drug to use by or on the order of a licensed veterinarian. For subcutaneous use in dogs and cats only. Federal law restricts this drug to use by or on the order of a licensed veterinarian. Maximum treatment should not exceed 2 injections. For subcutaneous use in dogs and cats only.
- High: Federal law restricts this drug to use by or on the order of a licensed veterinarian. For subcutaneous use in dogs and cats only. Federal law restricts this drug to use by or on the order of a licensed veterinarian. Maximum treatment should not exceed 2 injections. For subcutaneous use in dogs and cats only.
- https://animaldrugsatfda.fda.gov · fda_animal_drugs · Contraindication source
Adverse Reactions
Snapshot first, detailed rows second. This section summarizes signal data and is not a diagnosis.
Tap or hover a reaction to see what it means in plain language.
Most Reported Reactions
| Reaction | Cases | Species | Serious cases |
|---|---|---|---|
| 2 | Cat, Dog | 2 | |
| 2 | Cat, Dog | 2 | |
| 1 | Dog | 1 | |
| 1 | Dog | 1 | |
| 1 | Cat | 1 | |
| 1 | Dog | 1 | |
| 1 | Dog | 1 | |
| 1 | Cat | 1 |
Species coverage: Dog (19) Cat (13)
View detailed reaction table
| Reaction | Species | Seriousness | Frequency | Reports |
|---|---|---|---|---|
| Cat | Serious | - | 1 | |
| Cat | Serious | - | 1 | |
| Dog | Serious | - | 1 | |
| Dog | Serious | - | 1 | |
| Cat | Serious | - | 1 | |
| Dog | Serious | - | 1 | |
| Cat | Serious | - | 1 | |
| Cat | Serious | - | 1 | |
| Cat | Serious | - | 1 | |
| Dog | Serious | - | 1 | |
| Cat | Serious | - | 1 | |
| Dog | Serious | - | 1 | |
| Dog | Serious | - | 1 | |
| Dog | Serious | - | 1 | |
| Dog | Serious | - | 1 | |
| Dog | Serious | - | 1 | |
| Dog | Serious | - | 1 | |
| Dog | Serious | - | 1 | |
| Cat | Serious | - | 1 | |
| Dog | Non-serious | - | 1 | |
| Cat | Serious | - | 1 | |
| Cat | Serious | - | 1 | |
| Cat | Serious | - | 1 | |
| Dog | Serious | - | 1 | |
| Dog | Serious | - | 1 | |
| Dog | Serious | - | 1 | |
| Cat | Serious | - | 1 | |
| Dog | Serious | - | 1 | |
| Dog | Serious | - | 1 | |
| Cat | Serious | - | 1 | |
| Dog | Serious | - | 1 | |
| Dog | Serious | - | 1 |
- https://api.fda.gov/animalandveterinary/event.json · adverse_reaction · openFDA case USA-USFDACVM-2025-US-054722
Storage & Handling
No storage/handling guidance is linked yet.
Documents
Official label facts are separated from secondary summaries.
Official documents: 4 • Secondary summaries: 0
- FOI Summary oA 200-812 Approved June 24, 2025.pdf · FOI
- Cefovecin Sodium for Injection · SPL
- ucm062340.pdf · FOI
- Convenia® · SPL
No source yet.
- https://animaldrugsatfda.fda.gov/adafda/app/search/public/document/downloadFoi/17145 · document · FOI
- https://animaldrugsatfda.fda.gov/adafda/app/search/public/spl/file/17466/Cefovecin%20Sodium%20for%20Injection · document · SPL
- https://animaldrugsatfda.fda.gov/adafda/app/search/public/document/downloadFoi/849 · document · FOI
- https://animaldrugsatfda.fda.gov/adafda/app/search/public/spl/file/171/Convenia%C2%AE · document · SPL
Promotional Materials (Marketing)
This content is marketing material and not clinical guidance.
No marketing assets are linked yet.
No source yet.
Technical appendix (vet reference)
Canonical medication sections are above. This legacy block remains available for deeper cross-reference without cluttering the primary workflow.
At a Glance
Quick facts and links to official labeling and safety signals.
- Medication catalog: Source PetWisePlus | Refreshed Feb 12, 2026, 10:44 PM UTC
-
Animal Drugs @ FDA:
Source FDA
| Refreshed Feb 16, 2026, 11:00 AM UTC
Applications/products are imported from FDA export data.
-
Animal Drugs @ FDA previews:
Source FDA
| Refreshed Feb 9, 2026, 3:05 AM UTC
Label highlights/doc links are fetched from FDA preview endpoints.
-
Animal Drug Product Listing Directory (NDC):
Source FDA
| Refreshed Feb 16, 2026, 11:00 AM UTC
Package/product NDCs from FDA’s electronic listing directory (XLS).
- openFDA reaction terms: Source FDA openFDA | Refreshed Feb 16, 2026, 11:02 AM UTC
- openFDA case summaries: Source FDA openFDA | Refreshed Feb 9, 2026, 3:20 AM UTC
Diagnosis-code mappings are not available for this medication yet.
Counseling and Monitoring Highlights
Global Pet owner/Vet mode is controlled in the header. This section avoids duplicate in-page persona tabs.
- Federal law restricts this drug to use by or on the order of a licensed veterinarian. For subcutaneous use in dogs and cats only. Federal law restricts this drug to use by or on the order of a licensed veterinarian. Maximum treatment should not exceed 2 injections. For subcutaneous use in dogs and cats only. (Contraindication, High)
Identifiers & Packages
Normalized identifiers (NDC/NADA/ANADA) and package metadata from regulator listings.
| Package NDC | Product NDC | Form / Route | Status |
|---|---|---|---|
| 17033-002-01 | 17033 | - | |
| 54771-1520-1 | 54771 | - |
Enriched Documents
Documents are tiered by source trust: Official, Clinical, Manufacturer, Marketing.
-
FOI Summary oA 200-812 Approved June 24, 2025.pdf
• FOI summary • Official
• July 1, 2025
FDA FOI summary for application 200812
-
ucm062340.pdf
• FOI summary • Official
• Oct. 2, 2017
FDA FOI summary for application 141285
Data Sources & Revision History
Every non-trivial field is expected to include provenance and update timestamps.
- contraindications: Federal law restricts this drug to use by or on the order of a licensed veterinarian. For subcutaneous use in dogs and cats only. Federal law restricts this dr… (Official, 2026-02-12)
- side_effects: Top reported reactions (openFDA): Vomiting, Lethargy (see also Central nervous system depression in 'Neurological'), Death, Anorexia, Diarrhoea, Not eating. (Official, 2026-02-12)
- usage: For the treatment of skin infections (wounds and abscesses) in cats caused by susceptible strains of Pasteurella multocida . For the treatment of skin infectio… (Official, 2026-02-12)
- side_effects updated 2026-02-12 22:44 by etl_backfill • Backfilled from existing medication fields
- contraindications updated 2026-02-12 22:44 by etl_backfill • Backfilled from existing medication fields
- usage updated 2026-02-12 22:44 by etl_backfill • Backfilled from existing medication fields
FDA Products & Applications (Animal Drugs @ FDA)
Official sponsor/proprietary-name/application-status records linked by active ingredient.
| Product | Sponsor | Application | Status | Published |
|---|---|---|---|---|
|
Cefovecin Sodium for Injection
RX
Cefovecin sodium
Lyophilized powder for injection
• Subcutaneous
|
Qilu Animal Health Products Co., Ltd. | ANADA 200-812 | Approved | Jul 1, 2025 |
|
Convenia®
RX
Cefovecin sodium
Powder
• Subcutaneous
|
Zoetis Inc. | NADA 141-285 | Approved | Oct 2, 2017 |
Data source: FDA Animal Drugs @ FDA (public search export).
What It's For (FDA Label Highlights)
Extracted from FDA Animal Drugs @ FDA product labeling. Always confirm details with your veterinarian.
Composition / specifications
For the treatment of skin infections (secondary superficial pyoderma, abscesses, and wounds) in dogs caused by susceptible strains of Staphylococcus intermedius and Streptococcus canis (Group G).
Administer 3.6 mg/pound (lb) (8 mg/kilograms (kg)) body weight as a single subcutaneous injection. A second subcutaneous injection of 3.6 mg/lb (8 mg/kg) may be administered if response to therapy is not complete.
For the treatment of skin infections (wounds and abscesses) in cats caused by susceptible strains of Pasteurella multocida.
Administer 3.6 mg/lb (8 mg/kg) body weight as a single, one-time subcutaneous injection.
FDA page: Open in Animal Drugs @ FDA
Composition / specifications
FDA page: Open in Animal Drugs @ FDA
Official Documents (FDA)
Direct links to FDA-hosted PDFs and SPL packages (when available).
-
Summary
Dogs:Â For the treatment of skin infections (secondary superficial pyoderma, abscesses, and wounds) in dogs caused by susceptible strains of Staphylococcus intermedius and Streptococcus canis (Group G).
Cats:Â For the treatment of skin infections (wounds and abscesses) in cats caused by susceptible strains of Pasteurella multocida.
FDA page: Open in Animal Drugs @ FDA
-
FOI ucm062340.pdf
Summary
For the treatment of skin infections (wounds and abscesses) in cats caused by susceptible strains of Pasteurella multocida.
- Convenia® (ZIP)
FDA page: Open in Animal Drugs @ FDA
Usage
For the treatment of skin infections (wounds and abscesses) in cats caused by susceptible strains of Pasteurella multocida . For the treatment of skin infections (secondary superficial pyoderma, abscesses, and wounds) in dogs caused by susceptible strains of Staphylococcus intermedius and Streptococcus canis (Group G).
Source: FDA Animal Drugs @ FDA • Reference
Contraindications
Federal law restricts this drug to use by or on the order of a licensed veterinarian. For subcutaneous use in dogs and cats only. Federal law restricts this drug to use by or on the order of a licensed veterinarian. Maximum treatment should not exceed 2 injections. For subcutaneous use in dogs and cats only.
Side Effects
No approved side-effect narrative is linked yet.
openFDA reaction signals are available for Dog 56 and Cat 56 (view top reported reactions).
Top Reported Reactions (openFDA)
Aggregated reaction terms from FDA openFDA reports (not verified; does not prove causation).
Data source: FDA openFDA Animal & Veterinary adverse event reports.
Adverse Event Case Summaries (openFDA)
These are individual FDA adverse event reports. They are unverified and do not prove the medication caused the reaction.
Cat, Snowshoe, Male, 1 year, 4.264 kilogram • Drug: MSK, Subcutaneous, Dose: 0.40 mL per animal • Reactions: Vomiting, Blood in vomit, Death, Anaphylaxis • Outcome: Died
- Report ID: USA-USFDACVM-2025-US-055626
- Serious AE: Yes
- Treated For AE: Yes
- Sex: Male
- Age: 1.00 Year
- Weight: 4.264 Kilogram
- Case-reported brand: MSK
- Case-reported manufacturer: MSK
- Route: Subcutaneous
- Dose: 0.40 mL per animal
Cat, Domestic Shorthair, Male, 2 year, 4.35 kilogram • Drug: MSK, Injection, Unknown • Reactions: Partial lack of efficacy, Medication error NOS • Outcome: Ongoing
- Report ID: USA-USFDACVM-2025-US-054729
- Serious AE: Yes
- Treated For AE: Yes
- Sex: Male
- Age: 2.00 Year
- Weight: 4.350 Kilogram
- Case-reported brand: MSK
- Case-reported manufacturer: MSK
- Route: Unknown
- Form: Injection
Cat, Domestic Longhair, Female, 17 year, 3.97 kilogram • Drug: MSK, Injection, Unknown • Reactions: Lack of efficacy - NOS, Blood in urine, Urine abnormalities NOS, Abnormal ultrasound finding, Abnormal cytology… • Outcome: Ongoing
- Report ID: USA-USFDACVM-2025-US-054722
- Serious AE: Yes
- Treated For AE: Yes
- Sex: Female
- Age: 17.00 Year
- Weight: 3.970 Kilogram
- Case-reported brand: MSK
- Case-reported manufacturer: MSK
- Route: Unknown
- Form: Injection
Cat, Domestic Shorthair, Female, 12 year, 2.948 kilogram • Drug: MSK, Injection, Subcutaneous, Dose: 0.30 mL per animal • Reactions: Hiding, Wobbliness, Dilated pupils, Nasal discharge, Death… • Outcome: Died
- Report ID: USA-USFDACVM-2025-US-054748
- Serious AE: Yes
- Treated For AE: No
- Sex: Female
- Age: 12.00 Year
- Weight: 2.948 Kilogram
- Case-reported brand: MSK
- Case-reported manufacturer: MSK
- Route: Subcutaneous
- Form: Injection
- Dose: 0.30 mL per animal
Cat, Domestic Shorthair, Female, 16 year, 4.7 kilogram • Drug: MSK, Injection, Subcutaneous, Dose: 0.48 mL per animal • Reactions: Inappetence, Vomiting, Tiredness (lethargy), Hiding, Diarrhea • Outcome: Ongoing
- Report ID: USA-USFDACVM-2025-US-054740
- Serious AE: Yes
- Treated For AE: Yes
- Sex: Female
- Age: 16.00 Year
- Weight: 4.700 Kilogram
- Case-reported brand: MSK
- Case-reported manufacturer: MSK
- Route: Subcutaneous
- Form: Injection
- Dose: 0.48 mL per animal
Dog, Shepherd Dog - Australian, Male, 6 year, 17.872 kilogram • Drug: MSK, Subcutaneous, Dose: 2.20 mL per animal • Reactions: Abscess NOS, Dehiscence, Dermatitis, Pain NOS, Fever… • Outcome: Euthanized
- Report ID: USA-USFDACVM-2025-US-055651
- Serious AE: Yes
- Treated For AE: Yes
- Sex: Male
- Age: 6.00 Year
- Weight: 17.872 Kilogram
- Case-reported brand: MSK
- Case-reported manufacturer: MSK
- Route: Subcutaneous
- Dose: 2.20 mL per animal
Dog, Chihuahua, Female, 11 year, 3.629 kilogram • Drug: MSK, Injection, Subcutaneous • Reactions: Paralysis NOS, Death, Unable to walk • Outcome: Died
- Report ID: USA-USFDACVM-2025-US-055109
- Serious AE: Yes
- Treated For AE: No
- Sex: Female
- Age: 11.00 Year
- Weight: 3.629 Kilogram
- Case-reported brand: MSK
- Case-reported manufacturer: MSK
- Route: Subcutaneous
- Form: Injection
Dog, Siberian Husky, Female, 8.1 year, 26.85 kilogram • Drug: MSK, Injection, solution, Subcutaneous • Reactions: Difficulty to rise, Skin lesion NOS, Skin scab, Increased skin sensitivity • Outcome: Ongoing
- Report ID: USA-USFDACVM-2025-US-055654
- Serious AE: No
- Treated For AE: No
- Sex: Female
- Age: 8.10 Year
- Weight: 26.850 Kilogram
- Case-reported brand: MSK
- Case-reported manufacturer: MSK
- Route: Subcutaneous
- Form: Injection, solution
Data source: FDA openFDA Animal & Veterinary adverse event reports.
Overdose Information
No approved overdose-management text is linked yet. If overdose is suspected, contact a veterinarian or emergency clinic immediately.
Storage & Handling
No approved storage guidance is linked yet for this ingredient. Use manufacturer packaging and veterinary guidance for handling/storage.
Share Your Thoughts
Let others know your experience or advice regarding this medication.
This medication has not been reviewed by a veterinarian yet.